Sectoral Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.65M | Sell |
12,200
-4,600
| -27% | -$1.02M | 2.2% | 12 |
|
|
2025
Q4 | $3.84M | Buy |
16,800
+2,000
| +14% | +$456K | 3.08% | 8 |
|
|
2025
Q3 | $3.43M | Hold |
14,800
| – | – | 2.12% | 14 |
|
|
2025
Q2 | $2.75M | Hold |
14,800
| – | – | 1.81% | 10 |
|
|
2025
Q1 | $3.1M | Sell |
14,800
-4,000
| -21% | -$778K | 2.41% | 9 |
|
|
2024
Q4 | $3.34M | Buy |
18,800
+3,000
| +19% | +$552K | 2.23% | 7 |
|
|
2024
Q3 | $3.12M | Sell |
15,800
-29,150
| -65% | -$5.44M | 1.84% | 11 |
|
|
2024
Q2 | $7.71M | Buy |
44,950
+9,750
| +28% | +$1.62M | 3.13% | 7 |
|
|
2024
Q1 | $6.41M | Sell |
35,200
-11,100
| -24% | -$1.91M | 2.52% | 10 |
|
|
2023
Q4 | $7.18M | Buy |
46,300
+7,000
| +18% | +$1.02M | 3.09% | 7 |
|
|
2023
Q3 | $5.86M | Hold |
39,300
| – | – | 1.14% | 30 |
|
|
2023
Q2 | $5.29M | Hold |
39,300
| – | – | 0.88% | 54 |
|
|
2023
Q1 | $6.26M | Buy |
39,300
+2,000
| +5% | +$306K | 1.2% | 29 |
|
|
2022
Q4 | $6.03M | Sell |
37,300
-15,750
| -30% | -$2.41M | 1.17% | 34 |
|
|
2022
Q3 | $7.12M | Buy |
53,050
+12,750
| +32% | +$1.83M | 1.4% | 25 |
|
|
2022
Q2 | $6.17M | Sell |
40,300
-20,000
| -33% | -$3.06M | 1.24% | 28 |
|
|
2022
Q1 | $9.78M | Sell |
60,300
-8,500
| -12% | -$1.23M | 1.74% | 19 |
|
|
2021
Q4 | $9.32M | Sell |
68,800
-20,200
| -23% | -$2.39M | 1.4% | 29 |
|
|
2021
Q3 | $9.6M | Hold |
89,000
| – | – | 0.8% | 45 |
|
|
2021
Q2 | $10M | Sell |
89,000
-2,500
| -3% | -$282K | 0.81% | 52 |
|
|
2021
Q1 | $9.9M | Sell |
91,500
-3,750
| -4% | -$401K | 0.75% | 55 |
|
|
2020
Q4 | $10.2M | Buy |
95,250
+9,000
| +10% | +$865K | 0.72% | 50 |
|
|
2020
Q3 | $7.55M | Sell |
86,250
-18,500
| -18% | -$1.74M | 0.65% | 61 |
|
|
2020
Q2 | $10.3M | Buy |
104,750
+21,000
| +25% | +$1.85M | 0.94% | 48 |
|
|
2020
Q1 | $6.38M | Buy |
+83,750
| New | +$7.13M | 1.22% | 39 |
|
|
2018
Q1 | – | Sell |
-85,298
| Closed | -$8.25M | – | 69 |
|
|
2017
Q4 | $8.25M | Buy |
+85,298
| New | +$8.04M | 1.03% | 32 |
|
|
2014
Q4 | – | Sell |
-444,107
| Closed | -$25.7M | – | 65 |
|
|
2014
Q3 | $25.7M | Buy |
444,107
+172,366
| +63% | +$9.57M | 1.08% | 27 |
|
|
2014
Q2 | $15.3M | Sell |
271,741
-2,238
| -0.8% | -$117K | 0.65% | 43 |
|
|
2014
Q1 | $14.1M | Sell |
273,979
-198,693
| -42% | -$10M | 0.58% | 44 |
|
|
2013
Q4 | $25M | Buy |
+472,672
| New | +$23.2M | 1.08% | 32 |
|
Other funds holding ABBV
VCM
VPM
Sectoral Asset Management's ABBV Position: Q1 2026 in Review
Sectoral Asset Management reduced its AbbVie (ABBV) stake by 27% in Q1 2026, selling an estimated $1.02M and leaving 12,200 shares worth $2.65M. The position accounts for 2.2% of the portfolio, ranked #12.
Sectoral Asset Management first reported a position in ABBV in Q4 2013 and has held it in 30 quarters since. The position peaked at $25.7M in Q3 2014. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Sectoral Asset Management held 12,200 shares of AbbVie worth $2.65M as of Q1 2026.
- Sectoral Asset Management sold 4,600 AbbVie shares in Q1 2026, an estimated $1.02M.
- AbbVie made up 2.2% of Sectoral Asset Management's portfolio in Q1 2026, its #12 holding.
- Sectoral Asset Management first reported a position in AbbVie in Q4 2013 and has held it in 30 quarters since.
- Sectoral Asset Management's AbbVie position peaked at $25.7M in Q3 2014.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.